Greg Keenan's Insider Trades & SAST Disclosures

Greg Keenan's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 8,305 Common Stock done at an average price of $8.2 . Disclosure was reported to the exchange on March 7, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Aurinia Pharmaceuticals Inc
Greg Keenan Chief Medical Officer Sale of securities on an exchange or to another person at price $ 8.23 per share. 07 Mar 2025 8,305 153,484 (0%) 0% 8.2 68,350 Common Stock
Aurinia Pharmaceuticals Inc
Greg Keenan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 95,570 95,570 - - Employee Stock Option (right to buy)
Aurinia Pharmaceuticals Inc
Greg Keenan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 62,583 174,028 (0%) 0% 0 Common Stock
Aurinia Pharmaceuticals Inc
Greg Keenan Chief Medical Officer Sale of securities on an exchange or to another person at price $ 8.00 per share. 28 Feb 2025 12,239 161,789 (0%) 0% 8 97,912 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades